APP and Alzheimer disease: To unravel the potential function of Ms4a4a in AD, we utilized the APP/PS1 transgenic mouse, an Aβ‐driven AD mouse model.[37, 38, 39] We initially evaluated the expression levels of Ms4a4a in WT and APP/PS1 mice at 21 days and 7 months of age.